The future of cell and gene therapy may be defined less by discoveries and more by how the industry connects research and ...
A new study describes a gene therapy strategy that uses the brain's own glymphatic transport system to distribute engineered ...
Morning Overview on MSN
A baby got the first personalized CRISPR therapy and is now walking and talking
An infant diagnosed with a rare and life-threatening liver enzyme disorder became the first patient to receive a personalized ...
Explore the complex balance of risks and benefits in gene drives, a powerful tool in genetic engineering and disease control.
New mid-stage data from Biogen’s Ionis-partnered therapy diranersen served to both validate the tau hypothesis in Alzheimer’s ...
AstraZeneca and its partners at Ionis have been working on an antisense oligonucleotide therapy (eplontersen) to slow ...
India setting new benchmarks in medical research: Rajnath ...
Staff, families of patients and healthcare advocates rallied in front of the UCSF Benioff Children's Hospital in Oakland on ...
OrganaBio launches time-sensitive PBMC isolation in San Diego, extending rapid clinical sample processing to one of the ...
Opinion
4don MSNOpinion
The FDA drilled into patients’ skulls for a placebo. Heidi Overton can end that era
“Human life is not disposable, but a precious gift from God, with inherent worth and dignity.” It’s encouraging to learn that the author of those words, Dr. Heidi Overton, is reportedly one of three ...
As WHO predicts a 70 per cent rise in cancer cases globally by 2050, the pioneering treatments that could make a difference ...
1don MSNOpinion
Trust in the FDA is collapsing. It’s time to get really transparent about our food and our drugs
Patients with no other options are watching an agency turn on its own scientists — and the trust that took a century to build ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results